CanSino Biologics (CASBF) Short Interest Ratio & Short Volume → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free CASBF Stock Alerts C$2.10 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartShort InterestStock AnalysisChartShort Interest CanSino Biologics Short Interest DataCurrent Short Volume1,275,200 sharesPrevious Short Volume1,153,400 sharesChange Vs. Previous Month+10.56%Dollar Volume Sold Short$2.68 millionShort Interest Ratio / Days to Cover12,752.0Last Record DateApril 15, 2024Today's Trading Volume0 sharesAverage Trading Volume1,794 sharesToday's Volume Vs. Average0% Short Selling CanSino Biologics ? Sign up to receive the latest short interest report for CanSino Biologics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCASBF Short Interest Over TimeCASBF Days to Cover Over TimeCASBF Percentage of Float Shorted Over Time Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. CanSino Biologics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,275,200 shares C$2.68 million +10.6%N/A12752 $2.10 3/31/20241,153,400 shares C$2.15 million No ChangeN/A443.6 $1.86 3/15/20241,153,400 shares C$2.57 million No ChangeN/A5767 $2.23 2/29/20241,153,400 shares C$2.31 million No ChangeN/A0 $2.00 2/15/20241,153,400 shares C$2.31 million No ChangeN/A524.3 $2.00 1/15/20241,153,400 shares C$3.09 million +14.5%N/A11534 $2.68 Get the Latest News and Ratings for CASBF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CanSino Biologics and its competitors with MarketBeat's FREE daily newsletter. 12/31/20231,007,400 shares C$2.97 million No ChangeN/A143.5 $2.95 12/15/20231,007,400 shares C$2.97 million -0.2%N/A10074 $2.95 11/30/20231,009,800 shares C$3.52 million -1.8%N/A5049 $3.49 11/15/20231,028,200 shares C$3.61 million -6.1%N/A5141 $3.51 10/31/20231,094,800 shares C$3.20 million No ChangeN/A10948 $2.92 10/15/20231,094,800 shares C$3.28 million No ChangeN/A0 $3.00 9/30/20231,094,800 shares C$3.28 million No ChangeN/A10948 $3.00 9/15/20231,094,800 shares C$3.28 million +13.8%N/A10948 $3.00 8/31/2023962,400 shares C$2.75 million -43.3%N/A1145.7 $2.86 8/15/20231,698,600 shares C$6.62 million 0.0%N/A16986 $3.90 7/31/20231,699,200 shares C$6.30 million No ChangeN/A1416 $3.71 7/15/20231,699,200 shares C$5.95 million +11.1%N/A16992 $3.50 6/30/20231,529,000 shares C$4.86 million +12.7%N/A347.5 $3.18 6/15/20231,357,000 shares C$5.01 million +28.5%N/A2714 $3.69 5/31/20231,056,400 shares C$3.86 million +0.2%N/A132.1 $3.65 5/15/20231,054,600 shares C$4.75 million +0.1%N/A10546 $4.50 4/30/20231,054,000 shares C$5.06 million +1.0%N/A257.1 $4.80 4/15/20231,043,200 shares C$5.64 million -2.1%N/A5216 $5.41 3/31/20231,065,000 shares C$5.69 million +73.1%N/A10650 $5.34 3/15/2023615,200 shares C$4.74 million +336.9%N/A6152 $7.71 2/28/2023140,800 shares C$1.26 million +9.0%N/A704 $8.92 2/15/2023129,200 shares C$1.08 million -21.5%N/A646 $8.35 1/31/2023164,600 shares C$1.54 million -8.4%N/A823 $9.35 1/15/2023179,600 shares C$1.72 million -64.1%N/A256.6 $9.59 12/30/2022499,600 shares C$4.18 million -37.3%N/A555.1 $8.37 12/15/2022796,300 shares C$9.05 million +7.6%N/A612.5 $11.37 11/30/2022740,400 shares C$9.82 million -3.0%N/A2468 $13.26 11/15/2022763,000 shares C$11.49 million +7.1%N/A125.1 $15.06 10/31/2022712,200 shares C$0.00 -13.9%N/A1187 $0.00 CASBF Short Interest - Frequently Asked Questions What is CanSino Biologics' current short interest? Short interest is the volume of CanSino Biologics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 1,275,200 shares of CASBF short. Learn More on CanSino Biologics' current short interest. What is a good short interest ratio for CanSino Biologics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CASBF shares currently have a short interest ratio of 12,752.0. Learn More on CanSino Biologics's short interest ratio. Is CanSino Biologics' short interest increasing or decreasing? CanSino Biologics saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 1,275,200 shares, an increase of 10.6% from the previous total of 1,153,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short CanSino Biologics stock? Short selling CASBF is an investing strategy that aims to generate trading profit from CanSino Biologics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CanSino Biologics? A short squeeze for CanSino Biologics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CASBF, which in turn drives the price of the stock up even further. How often is CanSino Biologics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CASBF, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: 1933 Industries Short Interest 4Cable TV International Short Interest 4Front Ventures Short Interest AB Science Short Interest Acreage Short Interest Acreage Short Interest Aleafia Health Short Interest Almirall Short Interest Alvotech Short Interest American Green Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:CASBF) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve GoldRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy